At the age of 8, both his hands were successfully transplanted by four medical teams in a cutting-edge medical procedure which took around 11 hours in July 2015.
A research team from the University at Buffalo devised a technique named lung-on-a-chip technology using microlithography, where lab-grown lung tissue was placed upon a thin and flexible chip array. Fibrosis was artificially induced, where the lung cells were contracted and stiffened leading to scars in alveoli cells. This lung-on-a-chip technology could successfully test varied potential treatments against pulmonary fibrosis.
mHealth Application developer company Blink Health, brought legal charges against MedImpact Healthcare system, claiming the company to be a peddler of opioids.
Determined to cap the profits of private hospitals in Delhi and the NCR region, Delhi health minister Satyendra Jain has announced an array of new rules. He clearly stated that hospitals will be mandated to sell essential medicines at MRP and can no longer charge a markup.
With a view to reducing waiting time for patients, a group of doctors in a Nigerian hospital has unveiled a mobile app. The app is expected to bring a paradigm change in healthcare delivery services in the country.
Global healthcare is being led by the US with China following close behind. Europe is simply being a spectator to the developments that are unfolding on a global level.
A startup company called Nanochon secure 1st place at the 3DHEALS conference this year after delivering its pitch to a group of investors including Asimov Ventures, GE Ventures, Digital Industrialist.
A new form of the deadly disease named pneumoconiosis or black lung disease has become more prevalent especially among coal miners in the US, with mining experience of more than ten years.
The research study revealed that tumor growth could be reduced by targeting the expression of Beta3-integrin along with microtubule-targeting agents (MTAs) chemotherapy. Beta3-integrin was the better anti-angiogenic target since it was expressed in tumor blood vessels, unlike normal cells.
To diagnose any kind of gastrointestinal problems, an ingestible sensor equipped with a genetically engineered bacteria was developed by an MIT research team. This ‘bacteria-on-a-chip’ combined sensors with ultra-low-power electronics, which could convert the bacterial response into a wireless signal that can be read by a smartphone.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.